Development and Characterization of Orodispersible Tablets Containing Sumatriptan Succinate and Feverfew for the Treatment of Migraine
Background Migraine a chronic neurological disorder is characterized by moderate to severe headache episodes. Sumatriptan succinate an FDA-approved treatment for migraine in adults has demonstrated efficacy. Meanwhile Feverfew with a traditional application for fever and migrain...
Saved in:
| Main Authors: | Swati Modgekar, Vijayanand Pujari, Rashmi Surve, Rahul Koli |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Rajiv Gandhi University of Health Sciences
2024-01-01
|
| Series: | RGUHS Journal of Pharmaceutical Sciences |
| Online Access: | https://journalgrid.com/view/article/rjps/12434278 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Utilization of N-Bromosuccinimide as a Brominating Agent for the Determination of Sumatriptan Succinate in Bulk Drug and Tablets
by: Kudige N. Prashanth, et al.
Published: (2013-01-01) -
Development of a Hydrocortisone Orodispersible Thin Film Containing Its Succinate Prodrug
by: Clément Boisseillier, et al.
Published: (2025-01-01) -
Sensitive Bromatometric Methods for the Determination of Sumatriptan Succinate in Pharmaceutical Formulations
by: K. V. V. Satyanarayana, et al.
Published: (2011-01-01) -
Production technologies and formulation strategies in development of orodispersible tablets (ODTs)
by: Stevche Acevski, et al.
Published: (2024-12-01) -
Development and characterization of bilastine nanosuspension for enhanced dissolution in orodispersible films
by: Sarah Adnan Oudah, et al.
Published: (2025-01-01)